Dextromethorphan and guaifenesin use need to be monitored very carefully in clients with "bad metabolizer" CYP2D6 enzyme levels and clients who are sedated. This mix medication contains a massive median toxic dose (TD50) to median productive dose (ED50) ratio (or therapeutic index) in these people. Effects with the medical demo https://kameronngsep.blogtov.com/10615894/helping-the-others-realize-the-advantages-of-dextromethorphan-dxm-for-sale-in-germany